Journal
CLINICAL INFECTIOUS DISEASES
Volume 67, Issue 1, Pages 134-136Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciy035
Keywords
antibiotics; fluoroquinolones; resistance
Categories
Funding
- Centers for Disease Control and Prevention
- National Institutes of Health [1R01AI125642-01, R21HD090955]
- Agency for Healthcare Research and Quality [K08 HS23320-03]
- Centers for Disease Control and Prevention (CDC/NCEZID) [17IPA1708453]
Ask authors/readers for more resources
The Food and Drug Administration warned against fluoroquinolone use for conditions with effective alternative agents. An estimated 5.1% of adult ambulatory fluoroquinolone prescriptions were for conditions that did not require antibiotics, and 19.9% were for conditions where fluoroquinolones are not recommended first-line therapy. Unnecessary fluoroquinolone use should be reduced.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available